Manufacture of Urinalysis Test Strips

The contract seeks the manufacture of urinalysis diagnostic test strips capable of detecting multiple analytes, fully compliant with the technical specifications set by the Defense Logistics Agency and the regulatory requirements of the Food and Drug Administration for medical devices. This subcontract is part of a broader initiative by the Department of Defense’s Medical Supply Chain to ensure reliable, high-quality diagnostic tools are available for military medical operations. Production must adhere to stringent quality control standards and be performed in a manner that meets all federal medical device manufacturing guidelines, ensuring accuracy, safety, and consistency in clinical results. The solicitation is open for responses until August 3, 2026, with performance expected to be delivered to the designated military postal address in FPO, ZIP 96663-1290. The NAICS code 325412 identifies the industry classification as medical and surgical instrument manufacturing, underscoring the precision engineering and sterile production environment required. While no set-aside provisions are specified, the contract is structured as a subcontract, indicating it may be awarded to a vendor supporting a prime contractor or part of an established supply chain. All bids must demonstrate capability to consistently produce FDA-compliant, DLA-spec test strips under high-volume conditions with full traceability and documentation.